ElevateBio operates a dual-platform model: Life Edit handles gene editing R&D, while BaseCamp runs cGMP manufacturing for advanced cell and gene therapies. The tech stack (Veeva, ServiceNow, LMS, MES, SCADA, SAP) reflects a heavily regulated biotech manufacturer managing compliance, process control, and facility operations at scale. Current hiring acceleration in engineering and manufacturing, combined with active projects around MES implementation, new facility startup in Pittsburgh, and process equipment commissioning, signals expansion of manufacturing capacity and operational maturity.
ElevateBio is a biotechnology company that develops and manufactures genetic medicines through two integrated businesses. Life Edit is a gene editing R&D operation; BaseCamp is an end-to-end process development and cGMP manufacturing facility providing contract services for cell and gene therapy programs. The company operates in Waltham, Massachusetts, with a new manufacturing facility being brought online in Pittsburgh. With 201–500 employees, ElevateBio serves biotech partners seeking both scientific expertise and regulated manufacturing capacity. The organization is scaling across engineering, manufacturing, and quality functions to support growing therapeutic programs and facility buildout.
ElevateBio operates two core businesses: Life Edit (gene editing R&D) and BaseCamp (cGMP manufacturing and process development for genetic medicines). It commercializes these capabilities through partnerships with therapeutic developers.
ElevateBio uses Veeva, ServiceNow, SAP, LIMS, MES, SCADA, PLCs, and BACnet for manufacturing operations, compliance, quality, and facility control. Production management is powered by Basecamp, Asana, and traditional Office tools.
Other companies in the same industry, closest in size